BNGO News and Press, Bionano Genomics Inc. From 08/15/22

Turquoise Hill Resources ( TRQ ) -18% after Turquoise Hill rejects Rio Tinto's bid to take control of huge Mongolia mine . Arcadia Biosciences ( RKDA ) -18% to raise $5M in securities offering . Root ( ROOT ) -17% . TREASURE GLOBAL ( TGL ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Following brewing clinical momentum, shares of Bionano Genomics (NASDAQ: BNGO ) — a biotechnology firm specializing in nanoscale imaging and analytics — soared on Thursday. This came after the company an...

Life sciences company Bionano Genomics ( NASDAQ: BNGO ) added ~36% to reach an eight-month high on Thursday after the company announced the publication of a study highlighting the use of optical genome mapping (OGM) in the analysis of certain genetically-driven disorders. ...

SAN DIEGO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first study to evaluate the utility of optical genome mapping (OGM) in the analysis of repeat expansion disorders. Repeat expansion disorders are a class of disorders th...

Image source: The Motley Fool. Bionano Genomics, Inc (NASDAQ: BNGO) Q2 2022 Earnings Call Aug 04, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Bionano Genomics, Inc (BNGO) Q2 2022 Earnings Call Transcript

Bear markets are scary times to be investing, but investors willing to pick up discounted shares while uncertainty is high are setting themselves up for big gains down the road. Let's examine a few arguments in favor of sitting out on growth stocks until the bear market resides and a few in...

Bionano Genomics, Inc. (BNGO) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - Chief Executive Officer Christopher Stewart - Chief Financial Officer Conference Call Participants ...

Shares of small-cap pharmaceutical company Bionano Genomics ( NASDAQ: BNGO ) fell 8.1% to $2.16 in postmarket trading, after the genome analysis firm reported a wider Q2 loss and a significant fall in quarterly gross margin. It is worth noting that BNGO stock had gai...

Bionano Genomics press release ( NASDAQ: BNGO ): Q2 Net loss of $32.16M. Revenue of $6.67M (+72.8% Y/Y) beats by $0.39M . Gross margin for Q2 2022 was 22%, compared to 37% from Q2 2021 At June 30, 2022, the Company had cash, cash equivalents, and available...